Exome Asset Management LLC / 430
Exome Asset Management LLC’s Terns Pharmaceuticals Inc Position
Does Exome Asset Management LLC own Terns Pharmaceuticals Inc (430)? Not currently — the last reported position was 227.8K shares worth $1M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q1 2024
Shares
227.8K
% of Portfolio
+1.28%
Quarters Held
1
position exited
Position History 430
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2024 | 227.8K | $1M | +1.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of 430.